Aortic valve stenosis: from genetics to physiopathology

Aortic valve calcification: The role of lipoprotein (a)

Florian Kronenberg, Innsbruck, Austria

Genetic factors underlying aortic valve calcification

Johanna Kuusisto, Joensuu, Finland

Influence of genes on the susceptibility to atherosclerosis

Novel insight into the genetics of hypetriglyceridemia

Jacqueline Dron, Hamilton, Canada

Polygenic and clinical risk scores and their impact on age of onset and prediction of cardiovascular diseases

Samuli Ripatti, Helsinki, Finland

Mitochondrial dysfunction and vascular health

Cardiovascular risk in survivors of childhood cancer

LC Kremer, Amsterdam, The Netherlands

Role of SIRT3 in mitochondrial dysfuction and cardiovascular diseases

Martin Bennett, United Kingdom

Omega 3 fatty acids and CVD risk: Facts or fantasy?

Benefits of long-chain omega-3 fatty acids : from bench to bedside

Phil Calder, Southampton, United Kingdom

The evolving story of omega-3 trials and reduction of CVD risk

Jane Armitage, Oxford, United Kingdom

Targeting apoCIII or ANGPTL3 to lower TGs

ANGPTLs as a novel targets to reduce CVD risk

Sander Kersten, Wageningen, The Netherlands

Role apo apoC-III in the metabolism of triglyceride rich lipoproteins

Marja-Riitta Taskinen, Helsinki, Finland

Defective efferocytosis and impaired resolution of inflammation

Impaired resolution of inflammation – role of lipid mediators

Magnus Bäck, Stockholm, Sweden

Macrophage immunometabolism in atherosclerosis

Ira Tabas, New York, USA

Extracellular matrix components: guardians of vascular health

Dietary polyphenols and arterial stiffness

Guido R.Y. De Meyer, Antwerp, Belgium

The role of smooth muscle cells in plaque stability

Helle F. Joergensen, Cambridge, United Kingdom

Imaging the vulnerable plaque

Imaging neoatherosclerosis in coronary stent thrombosis

Michael Joner, Munich, Germany

CTA Imaging in the Full Assessment of Coronary Disease Noninvasive Approach to Plaque Anatomy, Ischemia and Risk

Patrick Serruys, The Netherlands

Immunopathological responses elicited by lipoprotein retention in the arterial wall

Apolipoprotein E: a key player in the immunophatological process in atherosclerosis

Christoph Binder, Vienna, Austria

Are mastcells welcomed in the atherosclerotic leasions?

Petri Kovanen, Helsinki, Finland

Association of neoadjuvant chemotherapy with cardiovascular risk

Filippo Crea, Rome, Italy

Share this: